CARD15: A pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis

American Journal of Human Genetics

Volumn 73, Issue 3, 2003, Pages 677-681

  Rahman, P ^a,d   Bartlett, S ^a   Siannis, F ^b   Pellett, F J ^c   Farewell, V T ^b   Peddle, L ^a   Schentag, C T ^c   Alderdice, C A ^a   Hamilton, S ^a   Khraishi, M ^a   Tobin, Y ^a   Hefferton, D ^a   Gladman, D D ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d St Clare's Mercy Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CHROMOSOME 16Q; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GEL ELECTROPHORESIS; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PLEIOTROPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PSORIATIC ARTHRITIS; SEQUENCE ANALYSIS;

STAPHYLOCOCCUS PHAGE 187;

EID: 0041885442     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/378076     Document Type: Article

References (22)

1. Bear JC, Nemec TF, Kennedy JC, Marshall WH, Power AA, Kolonel VM, Burke GB (1988) Inbreeding in outport Newfoundland. Am J Med Genet 29:649-660
2. Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nistic S, Chimenti S, Pallone F, Novelli G (2002) Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol 12:540-542
3. Cook RJ, Farewell VT (1996) Multiplicity considerations in the design and analysis of clinical trials. J R Statist Soc 159:93-110
4. Cox DR (1972) Regression models and life tables. J R Statist Soc 34:187-220
5. Enerback C, Martinsson T, Inerot A, Wahlstrom J, Enlund F, Yhr M, Swanbeck G (1997). Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). Acta Derm Venereol 77:273-276
6. Gladman DD (2002) Current concepts in psoriatic arthritis. Curr Opin Rheumatol 14:361-366
7. Gladman DD, Cheung C, Ng CM, Wade JA (1999) HLA C-locus alleles in psoriatic arthritis. Hum Immunol 60:259-261
8. Gladman DD, Schuckett R, Russell ML, Thorne JC, Schacter RK (1987) Psoriatic arthritis: clinical and laboratory analysis of 220 patients. QJM 62:127-141
9. Goodfield M (1994) Skin lesions in psoriasis. Baillieres Clin Rheumatol 8:295-316
10. Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cézard J-P, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel J-F, Sahbatou M, Thomas G (2001) Association of NOD2 leucine rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
11. Hugot J-P, Cho JH (2002) Update on genetics of inflammatory bowel disease. Curr Opin Gastroenterol 18:410-415
12. Karason A, Gudjonsson JE, Upmanyu R, Antonsdottir AA, Hauksson VB, Runasdottir EH, Jonsson HH, Gudbjartsson DF, Frigge ML, Kong A, Stefansson K, Valdimarsson H, Gulcher JR (2003) A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 72:125-131
13. Lee FI, Bellary SV, Francis C (1990) Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 85:962-963
14. Lesage S, Zouali H, Cézard J-P and the EPWG-IBD group, Colombel JF and the EPIMAD group, Belaiche J and the GETAID group, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot A-S, Thomas G, Hugot J-P (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845-857
15. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot J-P (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19-20
16. Moll JM, Wright V (1973) Familial occurrence of psoriatic arthritis. Ann Rheum Dis 32:181-201
17. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, Elder JT (1997) Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6:1349-1356
18. Nair RP, Stuart P, Ogura Y, Inohara N, Chia NVC, Young L, Henseler T, Jenisch S, Christophers E, Voorhees JJ, Nunez G, Elder JT (2001) Lack of association between NOD2 3020 InsC frameshift mutation and psoriasis. J Invest Dermatol 117:1671-1672
19. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
20. Vasey FB (1985) Etiology and pathogenesis of psoriatic arthritis. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis, Grune & Stratton, Orlando, FL, pp 45-57
21. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, Langelier, Pare P, Lapointe G, Cohen A, Daly MJ, Rioux JD (2002) CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71:74-83
22. Wright V, Moll JMH (1976) Psoriatic arthritis. In: Wright V, Moll JMH (eds) Seronegative polyarthritis, North Holland Publishing, Amsterdam, pp 169-223